|
|
|
|
|
CUSIP No. 09075A108 |
|
SCHEDULE 13G |
|
Page
10
of 16 Pages |
Bioventus Inc. (the “Issuer”)
|
(b) |
Address of Issuer’s Principal Executive Offices: |
4721 Emperor Boulevard, Suite 100
Durham, NC 27703
|
(a) – (c) |
Name of Persons Filing; Address; Citizenship: |
AMP-CF Holdings, LLC
C/O Ampersand Capital Partners
55 William Street, Suite 240
Wellesley, Ma 02481
Place of
Organization: Delaware
Ampersand CF Limited Partnership
C/O Ampersand Capital Partners
55 William Street, Suite 240
Wellesley, Ma 02481
Place of
Organization: Delaware
AMP-CF Management Company Limited Partnership
C/O Ampersand Capital Partners
55 William Street, Suite 240
Wellesley, Ma 02481
Place of
Organization: Delaware
AMP-CF MC LLC
C/O Ampersand Capital Partners
55 William Street, Suite 240
Wellesley, Ma 02481
Place of
Organization: Delaware
Ampersand 2020 Limited Partnership
C/O Ampersand Capital Partners
55 William Street, Suite 240
Wellesley, Ma 02481
Place of
Organization: Delaware
AMP-20 MC LLC
C/O Ampersand Capital Partners
55 William Street, Suite 240
Wellesley, Ma 02481
Place of
Organization: Delaware
AMP-20 Management Company Limited Partnership
C/O Ampersand Capital Partners
55 William Street, Suite 240
Wellesley, Ma 02481
Place of
Organization: Delaware